Navigation Links
OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
Date:8/13/2009

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning the potential activity and clinical benefit of OGX-427 and the anticipated clinical development activities and timing of these activities. Such forward-looking statements are subject to risks and uncertainties, including, among others: the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for fiscal year 2008. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... YORK, Dec. 17 Reportlinker.com ... report is available in its catalogue: ... (NPWT) Pipeline Technology and Market Forecasts ... ,, Negative Pressure Wound ... Forecasts to 2016 ,, Summary ...
(Date:12/17/2009)... ORLANDO, Fla., Dec. 17 MedX Limited, ... -branded medical exercise equipment and a subsidiary of ... the sale of 227 MedX exercise ... list of countries, including Australia, Germany, India, Scotland, ... sold MedX equipment will be used ...
(Date:12/17/2009)... Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced preliminary results ... for the first dose cohort, 200 mg bid, in an ... interferon and ribavirin (SOC) in HCV patients. 56% of ... (<15 IU/ml) at week 4, known as R apid ... 20% of patients receiving placebo plus SOC. ,, ...
Breaking Medicine Technology:Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 3Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 4Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 5Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 6WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm 47949 1Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm 47949 2Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm 47949 3Alaska Governor Sarah Palin to be Honored Before Sold Out Crowd at IGHL 30 28th 29 Anniversary Gala During First Visit to Long Island 47945 1Alaska Governor Sarah Palin to be Honored Before Sold Out Crowd at IGHL 30 28th 29 Anniversary Gala During First Visit to Long Island 47945 2Ohios Childrens Hospitals Release New Results of Collaboration Aimed at Saving Childrens Lives 47941 1Ohios Childrens Hospitals Release New Results of Collaboration Aimed at Saving Childrens Lives 47941 2Ohios Childrens Hospitals Release New Results of Collaboration Aimed at Saving Childrens Lives 47941 3
... Benchmark on MRSA,in Healthcare Facilities, WASHINGTON, June 21, 2007 /PRNewswire-USNewswire/ ... WHAT:, -- First nationwide study ... Staphylococcus aureus (MRSA), a virulent multi-drug resistant organism, ... -- MRSA prevalence study findings significantly exceed previous ...
... 2007 - Neurologix, Inc.,(OTCBB:NRGX) today announced the publication ... Lancet of positive results from the first ever,gene ... report of,direct gene transfer into a patient's own ... label Phase 1 study, conducted in 12 patients ...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
(Date:12/17/2009)... Americans fall down on prevention, experts say , , ... and surgeons are getting better at treating heart ... are ignoring the basic rules for preventing them, ... Association. , Topping the list: too little exercise, ... of adults surveyed last year reported no activity ...
(Date:12/17/2009)... likely to try alcohol, illegal drugs , , THURSDAY, Dec. ... cigarettes is riskier than using illicit drugs or binge ... may increase the likelihood that they,ll experiment with alcohol ... are on the right track with cigarette smoking and ... dangers of other substances," Pamela S. Hyde, administrator of ...
(Date:12/17/2009)... using virtually any smart phone , ... ... the world’s most trusted source for medical information delivered through ... decision application on the Google Android operating system. Skyscape’s extensive ... making the ability for medical professionals to download the latest ...
(Date:12/17/2009)... -- Reportlinker.com announces that a new market ... ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ,, The ... health industry executives with strategically significant competitor ... development and implementation of effective marketing and ... ,, To establish a comprehensive, ...
(Date:12/17/2009)... -- Today, CDC,s Morbidity and Mortality Weekly Report ... of state-level epidemiologists has decreased steadily since 2004, ... 2006. There was also a substantial decrease in ... epidemiology capacity for bioterrorism and emergency response. ... occupational health, substance abuse, and oral health, basic ...
Breaking Medicine News(10 mins):Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 3Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 4Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2
... Apple electronics stores in US cities aiming to be the first ... the planet, when they go on sale Friday. ,The ... in the palm of the hand, goes on sale at 6 ... armed with umbrellas and rain gear -- and a handful with ...
... called for taking advantage of the benefits of digital ... to help the needy in rural areas in a ... visit to the digital radiology centre at Electronics Corporation ... low cost digital radiography equipment and electronic medical records ...
... has said that Pakistan has the highest maternal and infant ... prepared by it, SPARC further said that around 10 million ... million children do not go to school, which is the ... number of street children is growing with almost 25,000 on ...
... transferred it from God to the medical profession' - George ... the cynosure of global attention. A country that churns the ... healthcare services. It is no longer wishful thinking that ... an important healthcare hub. ,India has ...
... the University of Kalyani, India, has found that plankton used ... offspring if reared in diluted urine. ,As ... at the university, mixed ground water with human urine from ... is often fed to hatchling fish in commercial fisheries. ...
... a project to save Tibetan folk songs from extinction. ... Tibetan Endangered Music Project (TEMP) aims at digitalizing and archiving ... the community. ,"The goal is to digitalize the ... want to record as many songs as possible," said Dawa ...
Other Medicine News:Health News:Tech Heads Go Gaga Waiting for Apple's IPhone 2Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 2Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 3Health News:Digital Music Project Aims to Save Tibetan Folk Songs from Extinction 2
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: